-
Sales warning slams Ozempic maker Novo Nordisk's stock
-
Can Vonn defy ACL rupture to win Olympic medal?
-
Breakthrough or prelude to attack? What we know about Iran-US talks
-
German far-right MP detained over alleged Belarus sanctions breach
-
MSF says its hospital in South Sudan hit by government air strike
-
Merz heads to Gulf as Germany looks to diversify trade ties
-
Selection process for future Olympic hosts set for reform
-
Serbian minister on trial over Trump-linked hotel plan
-
UK PM says Mandelson 'lied', regrets appointing him US envoy
-
Cochran-Siegle tops first Olympic downhill training
-
Gaza health officials say strikes kill 21 after Israel says shots wounded officer
-
Injured Vonn's Olympic bid is 'inspirational', ski stars say
-
Albania arrests 20 for toxic waste trafficking
-
US-Africa trade deal renewal only 'temporary breather'
-
Mir sets pace on Sepang day two, Yamaha absent
-
Xi, Putin hail 'stabilising' China-Russia alliance
-
GSK boosted by specialty drugs, end to Zantac fallout
-
UK's ex-prince leaves Windsor home amid Epstein storm: reports
-
Sky is the limit for Ireland fly-half Prendergast, says captain Doris
-
Stocks fluctuate after Wall St AI-fuelled sell-off
-
Feyi-Waboso reminds England great Robinson of himself
-
Starmer faces MPs as pressure grows over Mandelson scandal
-
HRW urges pushback against 'aggressive superpowers'
-
Russia demands Ukraine give in as UAE talks open
-
Gaza civil defence says 17 killed in strikes after Israel says shots wounded officer
-
France's Kante joins Fenerbahce after Erdogan 'support'
-
CK Hutchison launches arbitration over Panama Canal port ruling
-
Stocks mostly rise as traders ignore AI-fuelled sell-off on Wall St
-
Acclaimed Iraqi film explores Saddam Hussein's absurd birthday rituals
-
On rare earth supply, Trump for once seeks allies
-
Ukrainian chasing sumo greatness after meteoric rise
-
Draper to make long-awaited return in Davis Cup qualifier
-
Can Ilia Malinin fulfil his promise at the Winter Olympics?
-
CK Hutchison begins arbitration against Panama over annulled canal contract
-
UNESCO recognition inspires hope in Afghan artist's city
-
Ukraine, Russia, US negotiators gather in Abu Dhabi for war talks
-
WTO must 'reform or die': talks facilitator
-
Doctors hope UK archive can solve under-50s bowel cancer mystery
-
Stocks swing following latest AI-fuelled sell-off on Wall St
-
Demanding Dupont set to fire France in Ireland opener
-
Britain's ex-prince Andrew leaves Windsor home: BBC
-
Coach plots first South Africa World Cup win after Test triumph
-
Spin-heavy Pakistan hit form, but India boycott risks early T20 exit
-
Japan eyes Premier League parity by aligning calendar with Europe
-
Whack-a-mole: US academic fights to purge his AI deepfakes
-
Love in a time of war for journalist and activist in new documentary
-
'Unprecedented mass killing': NGOs battle to quantify Iran crackdown scale
-
Seahawks kid Cooper Kupp seeks new Super Bowl memories
-
Thousands of Venezuelans march to demand Maduro's release
-
AI, manipulated images falsely link some US politicians with Epstein
US breast cancer rate rising sharply even as deaths fall: study
Breast cancer rates are rising sharply in the United States, driven by increases among younger women and Asian Americans, a study said Tuesday.
The biennial report by the American Cancer Society found the number of cases grew by one percent each year from 2012 to 2021, even as the overall death rate continued its historic trend of decline, falling 44 percent from 1989 to 2022.
Breast cancer is the second most common cancer diagnosed among US women, and the second leading cause of death from cancer, after lung cancer.
Approximately one-in-eight women in the US will be diagnosed with invasive breast cancer in their lifetime and one-in-43, or two percent, will die from the disease.
Over the past decade, the report said, breast cancer rates grew faster for women under the age of 50 than those older -- 1.4 percent annually versus 0.7 percent annually -- for reasons that aren't immediately clear.
By race, Asian American women had the most rapid increase in incidence followed by Hispanic, which the paper said "may be related in part to the influx of new immigrants, who have elevated breast cancer risk."
Overall, the breast cancer mortality rate fell 44 percent from 33 deaths per 100,000 women in 1989 to 19 deaths per 100,000 in 2022, resulting in around 517,900 averted deaths.
But despite decades of medical advancements in treatment and earlier detection, the benefits have been felt unevenly.
Mortality has remained unchanged since 1990 among Native Americans, while Black women experience 38 percent more deaths than white women despite five percent lower cases.
The paper said these findings highlighted "disadvantages in social determinants of health" and "longstanding systemic racism and has translated to less access to quality care across the cancer continuum."
For example, although Black women report getting mammograms more than White women, "they are more likely to have screening at lower resourced facilities and/or those that are not accredited by the American College of Radiology," the study said.
The authors recommended increasing racial diversity in clinical trials as well as community partnerships that boost access to high-quality screening among underserved women.
In April, an influential US medical body recommended women should get screened for breast cancer every other year starting from the age of 40.
The US Preventive Services Task Force (USPSTF) had previously said that women in their 40s should make an individual decision about when to start mammograms based on their health history and reserved its mandatory recommendation for people turning 50.
X.AbuJaber--SF-PST